Methadone (MTD) antibody and antigen (hapten, BSA/OVA conjugated)

 Download 

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-SMT-230-Ag01	BSA-Methadone (MTD)	756
GMP-SMT-230-Ag02	OVA-Methadone (MTD)	756
GMP-SMT-230-Ab01	Anti-human Methadone (MTD) mouse monoclonal antibody (mAb)	1953
GMP-SMT-230-Ab02	Anti-human Methadone (MTD) human monoclonal antibody (mAb)	1953

Size： 1mg | 10mg | 100mg

Product Description

Cat No. of Products	GMP-SMT-230-Ag01
Product Name	BSA-Methadone (MTD)
Target/Biomarker	Methadone (MTD)
Expression platform	Synthetic
Isotypes	NA
Bioactivity validation	Methadone (MTD) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MTD level test of Pain () and related syndrome evaluation.
Tag	NA
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Methadone (MTD) / OVA-Methadone (MTD) is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-SMT-230-Ag02
Product Name	OVA-Methadone (MTD)
Target/Biomarker	Methadone (MTD)
Expression platform	Synthetic
Isotypes	NA
Bioactivity validation	Methadone (MTD) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MTD level test of Pain () and related syndrome evaluation.
Tag	NA
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Methadone (MTD) / OVA-Methadone (MTD) is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-SMT-230-Ab01
Product Name	Anti-human Methadone (MTD) mouse monoclonal antibody (mAb)
Target/Biomarker	Methadone (MTD)
Expression platform	Hybridoma
Isotypes	Mouse IgG
Bioactivity validation	Methadone (MTD) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MTD level test of Pain () and related syndrome evaluation.
Tag	mFc
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Methadone (MTD) / OVA-Methadone (MTD) is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-SMT-230-Ab02
Product Name	Anti-human Methadone (MTD) human monoclonal antibody (mAb)
Target/Biomarker	Methadone (MTD)
Expression platform	Hybridoma
Isotypes	Mouse IgG
Bioactivity validation	Methadone (MTD) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MTD level test of Pain () and related syndrome evaluation.
Tag	mFc
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Methadone (MTD) / OVA-Methadone (MTD) is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

1. Introduction to Methadone in In Vitro Diagnosis (IVD) Methadone, a small molecule with significant relevance in the realm of in vitro diagnosis (IVD), serves as a pivotal antigenic target. In this comprehensive exploration, we delve into the multifaceted role of Methadone within IVD, elucidating its critical applications, methodologies, and the rationale behind its measurement. This elucidation aids both healthcare professionals and researchers in understanding the broader implications of Methadone quantification within the IVD landscape. 2. The Role of Methadone in In Vitro Diagnosis Methadone assumes a central role in IVD through its deployment as a vital antigen in the development of diagnostic assays. Collaboratively employed with Genemedi's specialized anti-small molecules antibodies and small molecules competitive antigens, Methadone aids in achieving precise and specific detection and quantification of antibodies or immune responses specifically targeted against it. This strategic amalgamation of reagents and methodologies underpins the foundation of IVD, enabling the identification and quantification of Methadone-related phenomena with exceptional accuracy. 3. Clinical Monitoring and Methadone Measurement In the clinical sphere, the measurement of Methadone becomes a matter of paramount importance. Methadone features prominently in opioid maintenance therapy, a cornerstone of addiction treatment. Accurate and routine measurement of Methadone levels within patient samples is pivotal to its effective management. It ensures that patients receive optimal dosages, thus avoiding the risks associated with underdosing, such as withdrawal symptoms, and the perils of overdosing, which can result in life-threatening consequences. This clinical application of Methadone measurement contributes significantly to patient safety and therapeutic efficacy. 4. Substance Abuse Detection and Methadone Quantification Beyond clinical applications, Methadone is susceptible to recreational misuse and illicit usage. Therefore, the capacity to measure Methadone in various bodily fluids or tissues becomes an invaluable tool in the context of substance abuse detection. Robust and sensitive assays designed to quantify Methadone levels serve as the frontline defense in identifying unauthorized or non-prescribed usage. In settings such as addiction treatment programs and forensic analysis, this capability plays a pivotal role in safeguarding public health and ensuring adherence to prescribed medication regimens. 5. Pharmacokinetic Profiling and Personalized Medicine A profound understanding of Methadone's pharmacokinetics is fundamental to the realm of personalized medicine. Quantifying Methadone levels empowers healthcare providers to tailor dosages with precision, aligning them meticulously with individual patient requirements. This optimization not only enhances therapeutic outcomes but also mitigates potential side effects or adverse reactions associated with suboptimal dosing. Consequently, Methadone measurement is an indispensable tool in the pursuit of personalized healthcare, ensuring that patients receive treatment regimens tailored to their unique physiological profiles. 6. Research Advancements and Methadone-Specific Immune Responses Methadone, beyond its clinical applications, stands as a powerful asset in the field of scientific research, particularly in endeavors aimed at enhancing addiction treatment and pain management. The measurement of Methadone-specific immune responses fuels the development of innovative diagnostic assays and therapeutic modalities. By probing the intricacies of the immune system's reactions to Methadone, researchers gain valuable insights that transcend the confines of the clinic. This research not only contributes to a deeper understanding of Methadone's pharmacological properties but also opens doors to groundbreaking discoveries in the broader domain of healthcare. 7. Conclusion: The Multifaceted Significance of Methadone Measurement in IVD In conclusion, the measurement of Methadone within the context of in vitro diagnosis transcends its status as a diagnostic tool. It emerges as a linchpin in clinical monitoring, substance abuse detection, personalized medicine, and scientific research. This multifaceted significance underscores its pivotal role in advancing healthcare outcomes and reinforces the precision and efficacy of diagnostic methodologies. As the landscape of IVD continues to evolve, Methadone measurement remains at the forefront, shaping the future of healthcare.

About GDU